• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

三种可溶性转铁蛋白受体检测系统用于诊断缺铁性贫血的分析评估:一项回顾性研究。

Analytical evaluation of three soluble transferrin receptor measurement systems for diagnosis of iron deficiency anemia: A retrospective study.

机构信息

Department of Laboratory Medicine, Peking Union Medical College Hospital, CAMS, Beijing, China.

Department of Hematology, Peking Union Medical College Hospital, CAMS, Beijing, China.

出版信息

J Clin Lab Anal. 2020 Aug;34(8):e23342. doi: 10.1002/jcla.23342. Epub 2020 Apr 22.

DOI:10.1002/jcla.23342
PMID:32320096
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC7439353/
Abstract

BACKGROUND

Soluble transferrin receptor (sTfR) is a promising indicator of iron deficiency anemia (IDA). Here, we investigated the application value of sTfR assays based on three different methods for the diagnosis of IDA.

METHODS

The sTfR concentrations in two groups of patient specimens with high-level and low-level sTfR concentrations and in quality control materials were measured four times a day for five consecutive days to evaluate the precision of the three methods. We selected patients with IDA, anemia of chronic disease (ACD), or chronic diseases with iron deficiency anemia (CIDA), and apparently healthy subjects, and measured the serum sTfR concentrations in all subjects using the three different methods. The cutoff points for an IDA diagnosis using the three assays and their corresponding clinical sensitivities and specificities were calculated by receiver operating characteristic analysis.

RESULTS

For the diagnosis of IDA, the cutoff points of sTfR measured by the chemiluminescent, immunoturbidimetric, and immunonephelometric assays were 2.91, 6.70, and 2.48 mg/L, respectively. The corresponding sensitivities were 85.59%, 85.59%, and 85.59%, the specificities were 91.47%, 90.31%, and 90.70%, and area under the curve was 0.943, 0.944, and 0.936, respectively. The sTfR concentrations measured by the different methods were significantly higher in the IDA and CIDA groups than in the other two groups (P < .05).

CONCLUSIONS

The sTfR based on the three different measurement methods presented promising analytical performances and met the clinical requirements for sensitivity and specificity. However, the different measurement methods had markedly different cutoff points for IDA diagnosis, which should be critically considered in clinical practice.

摘要

背景

可溶性转铁蛋白受体(sTfR)是缺铁性贫血(IDA)有前途的指标。在这里,我们研究了基于三种不同方法的 sTfR 测定在 IDA 诊断中的应用价值。

方法

每天四次测量两组高浓度和低浓度 sTfR 浓度的患者标本以及质控材料的 sTfR 浓度,连续五天以评估三种方法的精密度。我们选择 IDA、慢性病贫血(ACD)或慢性病合并缺铁性贫血(CIDA)患者和明显健康的受试者,并使用三种不同的方法测量所有受试者的血清 sTfR 浓度。通过接收者操作特征分析计算三种检测方法的 IDA 诊断切点及其相应的临床灵敏度和特异性。

结果

对于 IDA 的诊断,化学发光法、免疫比浊法和免疫散射比浊法测定的 sTfR 切点分别为 2.91、6.70 和 2.48mg/L。相应的灵敏度分别为 85.59%、85.59%和 85.59%,特异性分别为 91.47%、90.31%和 90.70%,曲线下面积分别为 0.943、0.944 和 0.936。IDA 和 CIDA 组的 sTfR 浓度明显高于其他两组(P<.05)。

结论

基于三种不同测量方法的 sTfR 呈现出有前途的分析性能,满足灵敏度和特异性的临床要求。然而,不同的测量方法对 IDA 诊断的切点明显不同,在临床实践中应仔细考虑。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/dabc/7439353/86223cf78c44/JCLA-34-e23342-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/dabc/7439353/90b280b738b2/JCLA-34-e23342-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/dabc/7439353/820fb9c62370/JCLA-34-e23342-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/dabc/7439353/86223cf78c44/JCLA-34-e23342-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/dabc/7439353/90b280b738b2/JCLA-34-e23342-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/dabc/7439353/820fb9c62370/JCLA-34-e23342-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/dabc/7439353/86223cf78c44/JCLA-34-e23342-g003.jpg

相似文献

1
Analytical evaluation of three soluble transferrin receptor measurement systems for diagnosis of iron deficiency anemia: A retrospective study.三种可溶性转铁蛋白受体检测系统用于诊断缺铁性贫血的分析评估:一项回顾性研究。
J Clin Lab Anal. 2020 Aug;34(8):e23342. doi: 10.1002/jcla.23342. Epub 2020 Apr 22.
2
The diagnostic role of serum transferrin receptor in patients with various anemia.血清转铁蛋白受体在各类贫血患者中的诊断作用。
Zhonghua Yi Xue Za Zhi (Taipei). 2002 Feb;65(2):55-60.
3
Evaluation of serum transferrin receptor concentration in diagnosing and differentiating iron deficiency anaemia from anaemia of chronic disorders.评估血清转铁蛋白受体浓度在缺铁性贫血与慢性病贫血的诊断及鉴别诊断中的作用。
J Pak Med Assoc. 2005 Jan;55(1):13-6.
4
Improved differential diagnosis of anemia of chronic disease and iron deficiency anemia: a prospective multicenter evaluation of soluble transferrin receptor and the sTfR/log ferritin index.改善慢性病贫血和缺铁性贫血的鉴别诊断:可溶性转铁蛋白受体和 sTfR/铁蛋白指数的前瞻性多中心评估。
Am J Hematol. 2011 Nov;86(11):923-7. doi: 10.1002/ajh.22108. Epub 2011 Aug 2.
5
Sensitivity, specificity, and predictive value of serum soluble transferrin receptor at different stages of iron deficiency.血清可溶性转铁蛋白受体在缺铁不同阶段的敏感性、特异性及预测价值。
Ann Clin Lab Sci. 2005 Autumn;35(4):435-9.
6
Usefulness of soluble transferrin receptor and ferritin in iron deficiency and chronic disease.可溶性转铁蛋白受体和铁蛋白在缺铁及慢性病中的应用价值
Scand J Clin Lab Invest. 2005;65(7):571-6. doi: 10.1080/00365510500206542.
7
Utility of Access Soluble Transferrin Receptor (sTfR) and sTfR/log Ferritin Index in Diagnosing Iron Deficiency Anemia.可溶性转铁蛋白受体(sTfR)及sTfR/铁蛋白指数在诊断缺铁性贫血中的应用价值
Ann Clin Lab Sci. 2015 Summer;45(4):396-402.
8
Diagnostic significance of serum soluble transferrin receptors in various anemic diseases: the first multi-institutional joint study in Japan.血清可溶性转铁蛋白受体在各种贫血性疾病中的诊断意义:日本首次多机构联合研究
Haematologia (Budap). 2002;32(3):225-38. doi: 10.1163/15685590260461048.
9
Evaluation of serum transferrin receptor and sTfR ferritin indices in diagnosing and differentiating iron deficiency anemia from anemia of chronic disease.评价血清转铁蛋白受体和 sTfR 铁蛋白指数在诊断和鉴别缺铁性贫血与慢性病贫血中的作用。
Indian J Pediatr. 2010 Feb;77(2):179-83. doi: 10.1007/s12098-009-0302-z. Epub 2010 Jan 20.
10
[Clinical significance of serum transferrin receptor in differential diagnosis of anemia].血清转铁蛋白受体在贫血鉴别诊断中的临床意义
Zhonghua Nei Ke Za Zhi. 2004 Jun;43(6):423-5.

引用本文的文献

1
Effect of roxadustat on iron metabolism in patients with peritoneal dialysis: a real-world 24-week study.罗沙司他对腹膜透析患者铁代谢的影响:一项真实世界的 24 周研究。
Eur J Med Res. 2023 Nov 7;28(1):489. doi: 10.1186/s40001-023-01465-0.

本文引用的文献

1
The transferrin/log(ferritin) ratio: a new tool for the diagnosis of iron deficiency anemia.转铁蛋白/(铁蛋白)比值:诊断缺铁性贫血的新工具。
Clin Chem Lab Med. 2012 Feb 11;50(8):1343-9. doi: 10.1515/cclm-2011-0594.
2
Soluble transferrin receptor as a diagnostic laboratory test for detection of iron deficiency anemia in acute illness of hospitalized patients.可溶性转铁蛋白受体作为住院患者急性疾病中铁缺乏性贫血检测的诊断性实验室检查。
Isr Med Assoc J. 2011 Feb;13(2):96-8.
3
Evaluation of serum transferrin receptor and sTfR ferritin indices in diagnosing and differentiating iron deficiency anemia from anemia of chronic disease.
评价血清转铁蛋白受体和 sTfR 铁蛋白指数在诊断和鉴别缺铁性贫血与慢性病贫血中的作用。
Indian J Pediatr. 2010 Feb;77(2):179-83. doi: 10.1007/s12098-009-0302-z. Epub 2010 Jan 20.
4
Worldwide prevalence of anaemia, WHO Vitamin and Mineral Nutrition Information System, 1993-2005.全球贫血患病率,世界卫生组织维生素和矿物质营养信息系统,1993 - 2005年
Public Health Nutr. 2009 Apr;12(4):444-54. doi: 10.1017/S1368980008002401. Epub 2008 May 23.
5
Hyperferritinemia in autoimmunity.自身免疫性高铁蛋白血症
Isr Med Assoc J. 2008 Jan;10(1):83-4.
6
Iron deficiency anemia.缺铁性贫血
Am Fam Physician. 2007 Mar 1;75(5):671-8.
7
Anemia of chronic disease.慢性病贫血
N Engl J Med. 2005 Mar 10;352(10):1011-23. doi: 10.1056/NEJMra041809.
8
The cellular mechanisms of body iron homeostasis.机体铁稳态的细胞机制。
Biol Res. 2000;33(2):133-42. doi: 10.4067/s0716-97602000000200013.
9
High serum transferrin receptor level in anemia of chronic disorders indicates coexistent iron deficiency.慢性病性贫血患者血清转铁蛋白受体水平升高表明存在合并缺铁。
Am J Hematol. 2003 Mar;72(3):158-61. doi: 10.1002/ajh.10260.
10
Soluble transferrin receptor for the evaluation of erythropoiesis and iron status.用于评估红细胞生成和铁状态的可溶性转铁蛋白受体
Clin Chim Acta. 2003 Mar;329(1-2):9-22. doi: 10.1016/s0009-8981(03)00005-6.